logo image
☰ search icon
Active Pharmaceutical Ingredients Market

Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report, By Type (Innovative APIs Generic APIs), By Type of Drug (Prescription, Over the Counter), By Potency (Traditional APIs, High Potency APIs) By Region, Forecasts, 2024-2031

Report ID : 1768 | Published : 2024-06-11 | Pages: 180 | Format: PDF/EXCEL

Share

The Global Active Pharmaceutical Ingredients Market Size is valued at 150.0 billion in 2023 and is predicted to reach 274.42 billion by the year 2031 at a 7.94% CAGR during the forecast period for 2024-2031.

active pharmaceutical ingredients

Improvements in the production of active pharmaceutical ingredients (APIs) and the rise in chronic diseases, such as cancer and cardiovascular conditions, are responsible for the growth. In addition to altering geopolitical conditions, supportive government regulations for API production are accelerating market expansion.

Due to COVID-19's supply chain disruption, the API market is witnessing significant changes. Due to geopolitical circumstances and the desire to lessen reliance on China for API products, nations like India are favored over China for exporting API. The governments of numerous countries have also developed policies and provided incentives to encourage the production of API.

The global APIs market benefited from the COVID-19 pandemic. The pharmaceutical sector was key in treating COVID-19 symptoms such as high fever, cough, and cold. The active pharmaceutical components market expanded during the pandemic due to the pharma sector's increased prominence. After the COVID-19 outbreak was classified as a pandemic by the World Health Organization, a wide range of renowned pharmaceutical and biopharmaceutical businesses and fresh startups rushed up to develop treatments for the virus. 

Recent Developments:

  • In December 2021, The Chasse-sur-Rhône, France, location of Novasep, a provider of services and technologies for the life sciences industry, invested about EUR 6 million to upgrade its capabilities with regard to the newer generation APIs in fields like oncology, the central nervous system (CNS), and infectious diseases. 

Competitive Landscape

Some of the Major Key Players in the Active Pharmaceutical Ingredients Market are:

  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GSK PLC
  • Sanofi
  • Viatris Inc.
  • Divi's Laboratories Limited
  • Sandoz Group AG
  • Boehringer Ingelheim International Gmbh
  • Sk Inc.
  • Eli Lilly And Company
  • Merck Kgaa
  • Abbvie Inc.
  • Hoffmann-La Roche Ltd.
  • Astrazeneca
  • Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla
  • Evonik Industries Ag
  • Hikma Pharmaceuticals Plc
  • BASF SE
  • Alembic Pharmaceuticals Limited

Market Segmentation:

The active pharmaceutical ingredients market is segmented by type, synthesis, type of drug, potency, therapeutic applications, end-user. Based on type, the market is segmented into innovative APIs and generic APIs, the market is segmented by synthesis into synthetic APIs and biotech APIs, the market is segmented on the basis of type of drugs into prescription and over the counter, the market is segmented on the basis of potency into traditional APIs and high potency APIs, on the basis of therapeutic applications market is segmented into communicable diseases, oncology, diabetes, cardiovascular diseases, respiratory diseases, pain management and others therapeutic application, on the basis of end-user the market is segmented into pharmaceutical & biotechnology industry, contract research organization, contract manufacturing organization, Others,

The Innovative APIs Segment Witnessed Growth At A Rapid Rate

Inventive APIs controlled the majority. Increased R&D initiatives for the creation of innovative drugs and helpful government laws are credited with this expansion. Numerous innovative items are currently being developed as a consequence of intensive research in this area and are anticipated to be on sale throughout the projected period. It is anticipated that new players in this sector will fuel market expansion.

The North American Active Pharmaceutical Ingredients Market Holds A Significant Regional Revenue Share

North America now dominates the market for active pharmaceutical components, which is anticipated to last a few more years. Due to rising disease rates and an ageing population, this area is anticipated to see a gain in market share in the future. The country had to import many APIs from other countries because of the country's severe COVID-19 outbreak, and domestic producers also had to ramp up production to meet the demand.

The majority of its API needs are satisfied by imports from Asian markets. According to US trade statistics, China and India account for roughly 75–80% of all APIs imported into the US since they have well-established production bases and a significant labour force that caters to the pharmaceutical industry. Recent political and trade initiatives of the US government to raise import levies and taxes are anticipated to increase operational expenses and put more pressure on manufacturers' pricing. In order to guarantee the supply of high-quality goods to the US market, the FDA has also raised the application costs for brand-new medicine approvals and increased the frequency of periodic inspections carried out at various offshore contract manufacturing facilities. 

Active Pharmaceutical Ingredients Market Report Scope:

Report Attribute

Specifications

Market size value in 2023

USD 150 Bn

Revenue forecast in 2031

USD 274.42 Bn

Growth rate CAGR

CAGR of 7.94% from 2024 to 2031

Quantitative units

Representation of revenue in US$ Billion, and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends

Segments covered

By Type, By Synthesis, By Type of Drug, By Potency, By Therapeutic Application, By End-User

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia

Competitive Landscape

Pfizer Inc., Teva Pharmaceutical Industries Ltd., GSK PLC, Sanofi, Viatris Inc., Divi's Laboratories Limited, Sandoz Group AG, Boehringer Ingelheim International Gmbh, Sk Inc., Eli Lilly And Company, Merck Kgaa, Abbvie Inc., F. Hoffmann-La Roche Ltd., Astrazeneca, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla, Evonik Industries Ag, Hikma Pharmaceuticals Plc, BASF SE, Alembic Pharmaceuticals Limited

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Active Pharmaceutical Ingredients Market Snapshot
Chapter 4. Global Active Pharmaceutical Ingredients Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. By Type, & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type:
5.2.1. Innovative APIs
5.2.2. Generic APIs
Chapter 6. Market Segmentation 2: By Synthesis Estimates & Trend Analysis
6.1. By Synthesis & Market Share, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Synthesis:

6.2.1. Synthetic APIs
6.2.2. Innovative Synthetic APIs
6.2.2.1. Generic Synthetic APIs
6.2.3. Biotech APIs
6.2.3.1. By Type
6.2.3.1.1. Innovative Biotech APIs
6.2.3.1.2. Generic Biotech APIs
6.2.3.2. By Product
6.2.3.2.1. Monoclonal Antibodies
6.2.3.2.2. Hormones and Growth Factors
6.2.3.2.3. Fusion proteins
6.2.3.2.4. Cytokines
6.2.3.2.5. Therapeutic enzymes
6.2.3.2.6. Blood factors and Anti-coagulants
6.2.3.2.7. Recombinant vaccines
6.2.3.3. By Expression Systems
6.2.3.3.1. Mammalian expression systems
6.2.3.3.2. Microbial expression systems
6.2.3.3.3. Yeast expression systems
6.2.3.3.4. Insect expression systems
6.2.3.3.5. Other expression system

Chapter 7. Market Segmentation 3: By Type of Drug Estimates & Trend Analysis
7.1. By Type of Drug & Market Share, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type of Drug:

7.2.1. Prescription
7.2.2. Over the Counter

Chapter 8. Market Segmentation 4: By Potency Estimates & Trend Analysis
8.1. By Potency & Market Share, 2023 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Potency:

8.2.1. Traditional APIs
8.2.2. High Potency APIs

Chapter 9. Market Segmentation 5: By End-User Estimates & Trend Analysis
9.1. By End-User & Market Share, 2023 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-User:

9.2.1. Pharmaceutical & Biotechnology Industry
9.2.2. Contract Research Organization
9.2.3. Contract manufacturing Organization
9.2.4. Others

Chapter 10. Active Pharmaceutical Ingredients Market Segmentation 6: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By Type, 2024-2031
10.1.2. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By Synthesis, 2024-2031
10.1.3. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By Type of Drug, 2024-2031
10.1.4. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By Potency, 2024-2031
10.1.5. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
10.1.6. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts by country, 2024-2031

10.2. Europe

10.2.1. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type, 2024-2031
10.2.2. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By Synthesis, 2024-2031
10.2.3. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type of Drug, 2024-2031
10.2.4. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By Potency, 2024-2031
10.2.5. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By End-User, 2024-2031
10.2.6. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) by country, 2024-2031

10.3. Asia Pacific

10.3.1. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type, 2024-2031
10.3.2. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By Synthesis, 2024-2031
10.3.3. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type of Drug, 2024-2031
10.3.4. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By Potency, 2024-2031
10.3.5. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By End-User, 2024-2031
10.3.6. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) by country, 2024-2031

10.4. Latin America

10.4.1. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type, (US$ Million) 2024-2031
10.4.2. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By Synthesis, (US$ Million) 2024-2031
10.4.3. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type of Drug, (US$ Million) 2024-2031
10.4.4. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By Potency, (US$ Million) 2024-2031
10.4.5. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By End-User, (US$ Million) 2024-2031
10.4.6. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) by country, 2024-2031

10.5. Middle East & Africa

10.5.1. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type, (US$ Million) 2024-2031
10.5.2. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By Synthesis, (US$ Million) 2024-2031
10.5.3. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type of Drug, (US$ Million) 2024-2031
10.5.4. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By Potency, (US$ Million) 2024-2031
10.5.5. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By End-User, (US$ Million) 2024-2031
10.5.6. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) by country, 2024-2031

Chapter 11. Competitive Landscape

11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles


11.2.1. UPL
11.2.2. Pfizer Inc.
11.2.3. Teva Pharmaceutical Industries Ltd.
11.2.4. GSK PLC
11.2.5. Sanofi
11.2.6. Viatris Inc.
11.2.7. Divi's Laboratories Limited
11.2.8. Sandoz Group AG
11.2.9. Boehringer Ingelheim International Gmbh
11.2.10. Sk Inc.
11.2.11. Eli Lilly And Company
11.2.12. Merck Kgaa
11.2.13. Abbvie Inc.
11.2.14. F. Hoffmann-La Roche Ltd.
11.2.15. Astrazeneca
11.2.16. Dr. Reddy’s Laboratories Ltd.
11.2.17. Sun Pharmaceutical Industries Ltd.
11.2.18. Cipla
11.2.19. Evonik Industries Ag
11.2.20. Hikma Pharmaceuticals Plc
11.2.21. BASF SE
11.2.22. Alembic Pharmaceuticals Limited
11.2.23. Other Prominent Players

 

Segmentation of Active Pharmaceutical Ingredients Market-

Active Pharmaceutical Ingredients Market- By Type

  • Innovative APIs
  • Generic APIs

Active Pharmaceutical ingredient

Active Pharmaceutical Ingredients Market- By Synthesis

  • Synthetic APIs
  • Innovative Synthetic APIs
    • Generic Synthetic APIs
  • Biotech APIs
    • By Type
      • Innovative Biotech APIs
      • Generic Biotech APIs
    • By Product
      • Monoclonal Antibodies
      • Hormones and Growth Factors
      • Fusion proteins
      • Cytokines
      • Therapeutic enzymes
      • Blood factors and Anti-coagulants
      • Recombinant vaccines
    • By Expression Systems
      • Mammalian expression systems
      • Microbial expression systems
      • Yeast expression systems
      • Insect expression systems
      • Other expression system

Active Pharmaceutical Ingredients Market- By Type of Drug

  • Prescription
  • Over the Counter

Active Pharmaceutical Ingredients Market- By Potency

  • Traditional APIs
  • High Potency APIs

Active Pharmaceutical Ingredients Market- By End User

  • Pharmaceutical & Biotechnology Industry
  • Contract Research Organization
  • Contract manufacturing Organization
  • Others

Active Pharmaceutical Ingredients Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Active Pharmaceutical Ingredients Market?

Active Pharmaceutical Ingredients Market expected to grow at a 7.94% CAGR during the forecast period for 2024-2031

Pfizer Inc., Teva Pharmaceutical Industries Ltd., GSK PLC, Sanofi, Viatris Inc., Divi's Laboratories Limited, Sandoz Group AG, Boehringer Ingelheim In

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach
Related Reports
logo

Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.

  • facebook icon
  • twitter icon
  • linkedin icon
Category
Quick Links
Office Address